CNBC June 10, 2024
Key Points
– Abbott on Monday announced it has received FDA clearance for two new CGMs that will be available without a prescription.
– A CGM is a small sensor that pokes through the skin and tracks a person’s glucose levels in real-time. The tech is primarily used by patients with diabetes.
– Abbott’s new Libre Rio system is for patients with Type 2 diabetes that do not take insulin, while Lingo is designed for use by consumers that are trying to improve their health and wellness.
Abbott Laboratories announced Monday it received approval from the U.S. Food and Drug Administration for two new continuous glucose monitoring systems, including one for people who don’t have diabetes. Both will be available...
Today's Sponsors
Today's Sponsor